UK pricing agreement
England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right
Simon Stevens calls for 'fair prices' from companies
Still no breakthrough on Orkambi talks, MPs want answers
As other price deals go through, Orkambi stalled again
Spinraza managed access deal in England breaks deadlock for Biogen
Patient groups remain wary, call for changes to NICE
Novartis and Sanofi heads take on UK pharma leadership roles
Sector must fight for best Brexit outcome
The Orkambi row explained
Q&A and timeline
Is Orkambi deal close? Vertex meets again today with NHS England
Campaigners hopes rise after three year wait
Optimism on Orkambi in England as talks to resume
Scotland's deal puts pressure on NHS England and NICE
NHS England’s medicines chief: stop ‘salami slicing’ and get faster market access
Pressure will be maintained on costs, despite VPAS price cap deal
Greater Manchester backs move to outcome-based payment
Region teams up with Cancer Research UK to accelerate change